Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.16
(-0.72%)
CNY 15.16
(-0.72%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.07 Billion CNY | 414.31% |
| 2022 | -340.76 Million CNY | -114.45% |
| 2021 | 2.35 Billion CNY | 109.51% |
| 2020 | 1.12 Billion CNY | 12.43% |
| 2019 | 1 Billion CNY | -35.19% |
| 2018 | 1.54 Billion CNY | 12.25% |
| 2017 | 1.37 Billion CNY | 17.01% |
| 2016 | 1.17 Billion CNY | -20.43% |
| 2015 | 1.47 Billion CNY | 8.06% |
| 2014 | 1.36 Billion CNY | 24.36% |
| 2013 | 1.1 Billion CNY | 43.04% |
| 2012 | 769.2 Million CNY | 25.93% |
| 2011 | 610.81 Million CNY | 35.64% |
| 2010 | 450.3 Million CNY | 42.18% |
| 2009 | 316.7 Million CNY | 23.77% |
| 2008 | 255.88 Million CNY | 43.96% |
| 2007 | 177.74 Million CNY | -13.51% |
| 2006 | 205.5 Million CNY | 6.19% |
| 2005 | 193.51 Million CNY | 12.98% |
| 2004 | 171.27 Million CNY | 21.31% |
| 2003 | 141.18 Million CNY | 19.8% |
| 2002 | 117.84 Million CNY | 14.56% |
| 2001 | 102.87 Million CNY | 29.35% |
| 2000 | 79.53 Million CNY | 35.19% |
| 1999 | 58.82 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 179.89 Million CNY | -51.0% |
| 2024 Q1 | 295.21 Million CNY | 663.95% |
| 2024 Q2 | 367.09 Million CNY | 24.35% |
| 2023 Q3 | 325.32 Million CNY | -26.23% |
| 2023 Q1 | 264.58 Million CNY | 239.36% |
| 2023 Q2 | 441.02 Million CNY | 66.69% |
| 2023 FY | 1.07 Billion CNY | 414.31% |
| 2023 Q4 | 38.64 Million CNY | -88.12% |
| 2022 Q2 | 149.42 Million CNY | 125.1% |
| 2022 FY | -340.76 Million CNY | -114.45% |
| 2022 Q4 | 77.96 Million CNY | 46.36% |
| 2022 Q3 | 53.27 Million CNY | -64.35% |
| 2022 Q1 | -595.26 Million CNY | -167.81% |
| 2021 Q3 | 478.83 Million CNY | -29.5% |
| 2021 Q2 | 679.2 Million CNY | 110.3% |
| 2021 Q1 | 322.96 Million CNY | 1143.51% |
| 2021 FY | 2.35 Billion CNY | 109.51% |
| 2021 Q4 | 877.85 Million CNY | 83.33% |
| 2020 Q1 | 294.86 Million CNY | 325.75% |
| 2020 Q3 | 413.95 Million CNY | 5.84% |
| 2020 Q4 | 25.97 Million CNY | -93.73% |
| 2020 Q2 | 391.1 Million CNY | 32.64% |
| 2020 FY | 1.12 Billion CNY | 12.43% |
| 2019 FY | 1 Billion CNY | -35.19% |
| 2019 Q3 | 233.53 Million CNY | -48.14% |
| 2019 Q4 | -130.61 Million CNY | -155.93% |
| 2019 Q1 | 448.18 Million CNY | 154.43% |
| 2019 Q2 | 450.31 Million CNY | 0.47% |
| 2018 Q4 | 176.15 Million CNY | -60.33% |
| 2018 FY | 1.54 Billion CNY | 12.25% |
| 2018 Q3 | 444.01 Million CNY | -19.78% |
| 2018 Q2 | 553.48 Million CNY | 48.98% |
| 2018 Q1 | 371.51 Million CNY | 56.09% |
| 2017 Q4 | 238 Million CNY | -37.74% |
| 2017 FY | 1.37 Billion CNY | 17.01% |
| 2017 Q3 | 382.3 Million CNY | -12.73% |
| 2017 Q1 | 318.14 Million CNY | 83.57% |
| 2017 Q2 | 438.07 Million CNY | 37.7% |
| 2016 Q1 | 277.04 Million CNY | 6.6% |
| 2016 FY | 1.17 Billion CNY | -20.43% |
| 2016 Q4 | 173.31 Million CNY | -45.55% |
| 2016 Q3 | 318.32 Million CNY | -21.93% |
| 2016 Q2 | 407.74 Million CNY | 47.18% |
| 2015 Q4 | 259.89 Million CNY | -33.11% |
| 2015 Q1 | 345.51 Million CNY | 51.49% |
| 2015 FY | 1.47 Billion CNY | 8.06% |
| 2015 Q2 | 484.56 Million CNY | 40.24% |
| 2015 Q3 | 388.57 Million CNY | -19.81% |
| 2014 Q3 | 395.69 Million CNY | -14.44% |
| 2014 Q2 | 462.46 Million CNY | 62.57% |
| 2014 FY | 1.36 Billion CNY | 24.36% |
| 2014 Q4 | 228.08 Million CNY | -42.36% |
| 2014 Q1 | 284.46 Million CNY | 44.45% |
| 2013 Q3 | 302.52 Million CNY | -20.44% |
| 2013 Q1 | 244.73 Million CNY | 70.27% |
| 2013 FY | 1.1 Billion CNY | 43.04% |
| 2013 Q4 | 196.93 Million CNY | -34.9% |
| 2013 Q2 | 380.24 Million CNY | 55.37% |
| 2012 FY | 769.2 Million CNY | 25.93% |
| 2012 Q4 | 143.73 Million CNY | -41.9% |
| 2012 Q2 | 256.2 Million CNY | 73.51% |
| 2012 Q1 | 147.66 Million CNY | 68.65% |
| 2012 Q3 | 247.39 Million CNY | -3.44% |
| 2011 Q1 | 160.13 Million CNY | 26.13% |
| 2011 FY | 610.81 Million CNY | 35.64% |
| 2011 Q2 | 200.19 Million CNY | 25.02% |
| 2011 Q4 | 87.55 Million CNY | -46.26% |
| 2011 Q3 | 162.93 Million CNY | -18.61% |
| 2010 Q2 | 128.47 Million CNY | 91.58% |
| 2010 Q3 | 127.81 Million CNY | -0.51% |
| 2010 Q4 | 126.95 Million CNY | -0.67% |
| 2010 FY | 450.3 Million CNY | 42.18% |
| 2010 Q1 | 67.05 Million CNY | -26.56% |
| 2009 Q3 | 87.58 Million CNY | 2.49% |
| 2009 FY | 316.7 Million CNY | 23.77% |
| 2009 Q4 | 91.31 Million CNY | 4.25% |
| 2009 Q2 | 85.45 Million CNY | 63.22% |
| 2009 Q1 | 52.35 Million CNY | -46.7% |
| 2008 Q4 | 98.23 Million CNY | 65.39% |
| 2008 Q1 | 42.03 Million CNY | -36.54% |
| 2008 FY | 255.88 Million CNY | 43.96% |
| 2008 Q2 | 57.71 Million CNY | 37.31% |
| 2008 Q3 | 59.39 Million CNY | 2.91% |
| 2007 FY | 177.74 Million CNY | -13.51% |
| 2007 Q2 | 46.86 Million CNY | 130.34% |
| 2007 Q1 | 20.34 Million CNY | -74.17% |
| 2007 Q3 | 46.29 Million CNY | -1.21% |
| 2007 Q4 | 66.23 Million CNY | 43.07% |
| 2006 Q3 | 49.19 Million CNY | -2.58% |
| 2006 Q4 | 78.77 Million CNY | 60.12% |
| 2006 Q1 | 27.03 Million CNY | -65.34% |
| 2006 FY | 205.5 Million CNY | 6.19% |
| 2006 Q2 | 50.49 Million CNY | 86.79% |
| 2005 FY | 193.51 Million CNY | 12.98% |
| 2005 Q1 | 25.46 Million CNY | -63.15% |
| 2005 Q4 | 78 Million CNY | 69.95% |
| 2005 Q3 | 45.89 Million CNY | 3.95% |
| 2005 Q2 | 44.15 Million CNY | 73.4% |
| 2004 Q1 | 22.23 Million CNY | -63.71% |
| 2004 Q3 | 41.95 Million CNY | 10.4% |
| 2004 Q4 | 69.09 Million CNY | 64.71% |
| 2004 FY | 171.27 Million CNY | 21.31% |
| 2004 Q2 | 37.99 Million CNY | 70.89% |
| 2003 FY | 141.18 Million CNY | 19.8% |
| 2003 Q4 | 61.26 Million CNY | 127.9% |
| 2003 Q3 | 26.88 Million CNY | -19.56% |
| 2003 Q1 | 19.61 Million CNY | -54.01% |
| 2003 Q2 | 33.42 Million CNY | 70.41% |
| 2002 Q1 | 15.53 Million CNY | 0.0% |
| 2002 Q2 | 32.06 Million CNY | 106.4% |
| 2002 FY | 117.84 Million CNY | 14.56% |
| 2002 Q3 | 27.61 Million CNY | -13.88% |
| 2002 Q4 | 42.64 Million CNY | 54.45% |
| 2001 FY | 102.87 Million CNY | 29.35% |
| 2000 FY | 79.53 Million CNY | 35.19% |
| 1999 FY | 58.82 Million CNY | 0.0% |